OneMedNet Corp
ONMDNasdaqIndustrials · Services-Commercial Physical & Biological Research · DE · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | |
|---|---|---|---|---|---|
| Revenue | $1.4M | $643,000 | $1.0M | $1.2M | — |
| Operating income | −$9.7M | −$9.6M | −$6.9M | −$11.4M | −$585,405 |
| Net income | −$2.8M | −$2.1M | −$33.8M | −$6.2M | $5.1M |
| Total assets | $2.2M | $3.7M | $464,000 | $30.4M | $117.9M |
| Total liabilities | $5.1M | $19.7M | $13.9M | $21.2M | $9.2M |
| Equity | −$3.0M | −$15.9M | −$13.4M | −$26.4M | $14.4M |
| EPS (diluted) | $-0.06 | $-0.08 | $-4.65 | $0.03 | $0.44 |
| Shares out. | 30.8M | 23.9M | 23.6M | 4.6M | — |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- −711.3%
- Net margin
- −206.1%
- Return on equity
- 94.5%
- Return on assets
- −130.2%
- Return on capital (ROCE)
- —
- Liabilities / assets
- 237.8%
- Debt / equity
- —
- Book value / share
- $-0.10
- Revenue growth (YoY)
- 111.4%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Altman Z″ (distress)
- -197.32distress
- Accruals / assets
- 218.6%high accruals
- Piotroski F-Score
- 4/9mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 3 severe● 5 warning● 2 good- Negative shareholder equity
- Altman Z″ in the distress zone
- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Operating losses (negative operating margin)
- Reported a net loss
- High leverage (liabilities > 70% of assets)
- Negative operating cash flow
- High accruals — earnings-quality risk
- Strong return on equity (>15%)
- Revenue is growing year-over-year
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Kmissed a reporting deadline ↗Apr 1, 2025
- NT 10-Qmissed a reporting deadline ↗Nov 15, 2024
- NT 10-Qmissed a reporting deadline ↗May 14, 2024
- NT 10-Kmissed a reporting deadline ↗Apr 1, 2024
- NT 10-Qmissed a reporting deadline ↗Nov 14, 2023
- NT 10-Qmissed a reporting deadline ↗May 15, 2023
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Discovery Capital Management, Llc / CtPassive (13G)Nov 14, 2025
- Td Securities (Usa) LlcPassive (13G)Nov 14, 2025
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 557,591 | 1.8 | -25.0% |
| Apr 30, 2026 | 743,681 | 1.0 | +20.0% |
| Apr 15, 2026 | 619,780 | 2.0 | -18.1% |
| Mar 31, 2026 | 757,167 | 2.2 | -56.0% |
| Mar 13, 2026 | 1.7M | 1.2 | +446.8% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Delisting / listing-standard noticeApr 20, 2026
- Shareholder vote · Other material eventDec 23, 2025
- Director / officer changeNov 7, 2025
- Other material eventOct 9, 2025
- Other material eventSep 15, 2025
- Regulation FD disclosureJul 11, 2025
- Regulation FD disclosureJul 8, 2025
- Entered a material agreement · Unregistered equity sale · Other material eventJun 24, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.